Prospects for Enhancing Efficacy of Radioimmunotherapy

Abstract : Radioimmunotherapy has been in use for more than 20 years and has progressed significantly since its efficacy has first been demonstrated in hematology. Yet it still has limitations that prevent its large-scale clinical use. This chapter reviews recent developments to overcome these limitations including new antibody specifici-ties, pretargeting methods, fractionated injections, and the use of alpha emitters. Immuno-PET is also likely to assist in selecting patients for radioimmunotherapy, optimizing injected activities, and noninvasively monitoring therapy efficacy.
Document type :
Book sections
Complete list of metadatas

Cited literature [39 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02315459
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, October 14, 2019 - 2:50:32 PM
Last modification on : Tuesday, October 15, 2019 - 1:12:59 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Clément Bailly, Caroline Bodet-Milin, François Guérard, Caroline Rousseau, Michel Chérel, et al.. Prospects for Enhancing Efficacy of Radioimmunotherapy. Resistance to Ibritumomab in Lymphoma, pp.139-153, 2018, ⟨10.1007/978-3-319-78238-6_10⟩. ⟨inserm-02315459⟩

Share

Metrics

Record views

45